PubRank

F Jané

Author PubWeight™ 23.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pacifier use, early weaning, and cry/fuss behavior: a randomized controlled trial. JAMA 2001 1.48
2 Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency. Clin Pharmacol Ther 1999 0.99
3 Evaluation of the central effects of alcohol and caffeine interaction. Br J Clin Pharmacol 1995 0.92
4 Influence of renal function on the pharmacokinetics of ramipril (HOE 498). Am J Cardiol 1987 0.89
5 Antiandrogenic treatment of obsessive-compulsive neurosis. Acta Psychiatr Scand 1986 0.86
6 Evaluation of the methodological quality of clinical trial protocols. A preliminary experience in Spain. Eur J Clin Pharmacol 1993 0.84
7 Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose. Eur J Drug Metab Pharmacokinet 1992 0.83
8 Interactions between amphetamine and reserpine in vitro. Experientia 1969 0.83
9 Pre- and postsynaptic effects of sulpiride in the rat isolated vas deferens. J Pharm Pharmacol 1982 0.81
10 Toxic coma induced by anticholinergic eye drops. Br Med J (Clin Res Ed) 1987 0.80
11 [Experimental study of the psychomotor activity of magnesium-pemoline]. Rev Esp Fisiol 1967 0.79
12 Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacology. Methods Find Exp Clin Pharmacol 2002 0.79
13 Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranes. Eur J Pharmacol 1990 0.78
14 Beta-adrenergic blocking effects and cardiodepressant activity of penbutolol and its two optical isomers in the guinea-pig left atrium. Methods Find Exp Clin Pharmacol 1984 0.78
15 Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats. Pharmacol Biochem Behav 2000 0.77
16 Lack of correlation between lithium pharmacokinetic parameters obtained from plasma and saliva. Ther Drug Monit 1988 0.77
17 Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats. Eur J Pharmacol 1999 0.77
18 Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man. Int J Clin Pharmacol Ther Toxicol 1985 0.77
19 Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens. J Pharm Pharmacol 1968 0.77
20 Proof of safety of drugs: focus on vigilance. Methods Find Exp Clin Pharmacol 2002 0.77
21 Basics of PK-PD using QEEG: acute/repetitive administration, interactions. Focus on anxiolytics with different neurochemical mechanisms as examples. Methods Find Exp Clin Pharmacol 2002 0.76
22 Evaluation of psychotropic drug consumption related to psychological distress in the elderly: hospitalized vs. nonhospitalized. Neuropsychobiology 1990 0.76
23 Buspirone plasma concentrations. Clin Pharmacol Ther 1998 0.75
24 Buspirone and electroencephalography. Clin Pharmacol Ther 1995 0.75
25 Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia. Antimicrob Agents Chemother 1999 0.75
26 [Magnesium sulfate in the treatment of asthma]. Rev Clin Esp 1992 0.75
27 Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway. Neuropharmacology 1989 0.75
28 Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model. Eur Neuropsychopharmacol 1999 0.75
29 Gender related pharmacokinetics of diltiazem in healthy subjects. Int J Clin Pharmacol Ther 1995 0.75
30 Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability. Methods Find Exp Clin Pharmacol 2005 0.75
31 Carbamazepine-isoniazid interaction and on-line information retrieval. N Engl J Med 1983 0.75
32 [Hypersensitivity reactions to ethylenediamine]. Rev Clin Esp 1991 0.75
33 Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors. Methods Find Exp Clin Pharmacol 1982 0.75
34 Theophylline-isoniazid interaction. DICP 1989 0.75
35 UV-induced erythema model: a tool in dermatopharmacology for testing the topical activity of non-steroidal anti-inflammatory agents in man. Methods Find Exp Clin Pharmacol 1988 0.75
36 A drug interaction study between cicletanine and tolbutamide in healthy volunteers. Eur J Clin Pharmacol 1996 0.75
37 [Non-lineal kinetic behavior of theophylline. Apropos of a case]. Med Clin (Barc) 1986 0.75
38 Rotational behavior in dopamine nigrostriatal denervated rats: effects of a wide range of time intervals between apomorphine administrations. Pharmacol Biochem Behav 1999 0.75
39 Grounds for the integration of pharmacokinetic-pharmacodynamic data. Methods Find Exp Clin Pharmacol 1996 0.75
40 Quantifying drug-drug interactions in pharmaco-EEG. Clin EEG Neurosci 2006 0.75
41 Some aspects of the rat and guinea-pig isolated vas deferens preparation. Med Pharmacol Exp Int J Exp Med 1966 0.75
42 Bioavailability study of fosfosal and codeine administered alone or in combination. Int J Clin Pharmacol Ther Toxicol 1989 0.75
43 Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats. Eur J Pharmacol 2000 0.75
44 A preferential blocking effect of oxprenolol on alpha 1-adrenoceptors in the rat. J Pharm Pharmacol 1982 0.75
45 [Therapeutic advances in thromboembolic disease. I. Dihydroergotamine + heparin]. Sangre (Barc) 1981 0.75
46 Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats. Brain Res 2000 0.75
47 Rotational behaviour induced by theophylline in 6-OHDA nigrostriatal denervated rats is dependent on the supersensitivity of striatal dopaminergic receptors. Pharmacol Biochem Behav 1989 0.75
48 Effect of astemizole on allergic asthma. Ann Allergy 1992 0.75
49 [How can we optimize therapy with sustained-release theophyllines?]. Med Clin (Barc) 1988 0.75
50 Lack of antihistamine properties of single dose cinnarizine in man. Methods Find Exp Clin Pharmacol 1988 0.75
51 T-maze performance in rats following chronic neuroleptic treatment. Pharmacol Biochem Behav 1990 0.75
52 Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril. Methods Find Exp Clin Pharmacol 1996 0.75
53 Value of effort testing and acute drug testing in the evaluation of antiarrhythmic treatment. Eur Heart J 1987 0.75
54 Adverse drug reactions in HIV positive hospitalized patients. A one-year drug surveillance program: study design. Methods Find Exp Clin Pharmacol 1996 0.75
55 Possible mechanisms involved in the hyperthermic effect caused by reserpine after pretreatment with amphetamine or tranylcypromine in conscious rat. Methods Find Exp Clin Pharmacol 1982 0.75
56 Effect of continuous arteriovenous hemodialysis on ganciclovir pharmacokinetics. DICP 1990 0.75
57 Propafenone and a syndrome of the lupus erythematosus type. Ann Intern Med 1986 0.75
58 No sex-related pharmacokinetic and pharmacodynamic differences of captopril. Pharmacol Res 1997 0.75
59 Comparison between apomorphine and amphetamine-induced rotational behaviour in rats with a unilateral nigrostriatal pathway lesion. Neuropharmacology 1988 0.75